SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 12th, 2015 • Inpellis, Inc. • Pharmaceutical preparations • New York
Contract Type FiledNovember 12th, 2015 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of August 17, 2015, between Alterix Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
INTELLECTUAL PROPERTY PURCHASE AGREEMENTIntellectual Property Purchase Agreement • November 12th, 2015 • Inpellis, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledNovember 12th, 2015 Company Industry JurisdictionTHIS INTELLECTUAL PROPERTY PURCHASE AGREEMENT (the “Agreement”) is entered into as of October 24, 2015 (the “Effective Date”) by and between BioChemics, Inc., a Delaware corporation having an address at 300 Rosewood Drive, Suite 103, Danvers MA 01923 (“BioChemics”) and Inpellis, Inc., a Delaware corporation having an address at 30 Washington Avenue, Suite F, Haddonfield, NJ 08033 (“Inpellis”).
Alterix Inc. EMPLOYMENT AGREEMENTEmployment Agreement • November 12th, 2015 • Inpellis, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledNovember 12th, 2015 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (the “Agreement”), by and between Alterix Inc., a Delaware corporation (“Alterix”), and David R. Staskin, M.D. (the “Executive”) is effective as of September 1, 2015 (the “Effective Date”). Alterix and the Executive are sometimes referred to herein individually as a “Party” and collectively as the “Parties.” In consideration of the the mutual covenants and agreements contained herein and other good and valuable consideration, the receipt and sufficiency of which the Parties hereby acknowledge, the Parties, intending to be legally bound, agree as follows:
Alterix Inc. PROPRIETARY INFORMATION, ASSIGNMENT OF DEVELOPMENTS AND NON- COMPETITION AGREEMENTProprietary Information, Assignment of Developments and Non-Competition Agreement • November 12th, 2015 • Inpellis, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledNovember 12th, 2015 Company Industry JurisdictionTHIS PROPRIETARY INFORMATION, ASSIGNMENT OF DEVELOPMENTS AND NON-COMPETITION AGREEMENT (“Agreement”), by and between Alterix Inc., a Delaware corporation (“Alterix”), and Patrick Mooney, M.D. (the “Employee”), is effective as of June 11, 2015 (the “Effective Date”).
Amendment to Common Stock Purchase WarrantCommon Stock Purchase Warrant • November 12th, 2015 • Inpellis, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledNovember 12th, 2015 Company Industry JurisdictionAmendment to Common Stock Purchase Warrant between Logic International Consulting Group, LLC as (“Holder”) and Alterix, Inc., a Delaware Corporation (“Company”), dated this 10th day of June, 2015.
Alterix Inc. EMPLOYMENT AGREEMENTEmployment Agreement • November 12th, 2015 • Inpellis, Inc. • Pharmaceutical preparations • Pennsylvania
Contract Type FiledNovember 12th, 2015 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (the “Agreement”), by and between Alterix Inc., a Delaware corporation (“Alterix”), and Patrick Mooney, M.D. (the “Executive”) is effective as of June 11, 2015 (the “Effective Date”). Alterix and the Executive are sometimes referred to herein individually as a “Party” and collectively as the “Parties.” In consideration of the mutual covenants and agreements contained herein and other good and valuable consideration, the receipt and sufficiency of which the Parties hereby acknowledge, the Parties, intending to be legally bound, agree as follows:
LEASE STREAMWOOD ASSOCIATES/HADDONFIELD, LLC T/A 30 WASHINGTON AVENUE (“LANDLORD”) AND ALTERIX, INC. (“TENANT”)Lease Agreement • November 12th, 2015 • Inpellis, Inc. • Pharmaceutical preparations • New Jersey
Contract Type FiledNovember 12th, 2015 Company Industry JurisdictionThis Lease Agreement, made this day of September 2015, by and between STREAMWOOD ASSOCIATES/HADDONFIELD, LLC T/A 30 WASHINGTON AVENUE (C/O The Streamwood Company, 30 Washington Avenue Suite A-1, Haddonfield, New Jersey 08033) hereinafter called the “Landlord” and ALTERIX, INC. presently doing business at 625 Clinton Avenue, Haddonfield, NJ 08033 hereinafter called the “Tenant”.
JOINT OWNERSHIP AGREEMENTJoint Ownership Agreement • November 12th, 2015 • Inpellis, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledNovember 12th, 2015 Company Industry JurisdictionThis Joint Ownership Agreement (this “Agreement”) is effective as of October 24, 2015 (the “Effective Date”) by and between BioChemics, Inc., a Delaware corporation having an address at 300 Rosewood Drive, Suite 103, Danvers MA 01923 (“BioChemics”) and Inpellis, Inc., a Delaware corporation having an address at 30 Washington Avenue, Suite F, Haddonfield, NJ 08033 (“Inpellis”). BioChemics and Inpellis are each herein a “Party” and collectively, the “Parties.”
COMMON STOCK PURCHASE WARRANT To Purchase Shares of Common Stock of ALTERIX, INC.Security Agreement • November 12th, 2015 • Inpellis, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledNovember 12th, 2015 Company Industry JurisdictionThis COMMON STOCK PURCHASE WARRANT (this “Warrant”) certifies that, for services rendered and to be rendered, Logic International Consulting Group, L.L.C. or assignee (the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the effective date hereof, December 1, 2013 and on or prior to the close of business on the fifth (5th) anniversary of the date of this Warrant (the “Termination Date”), to subscribe for and purchase up to Four Million (4,000,000) shares of common stock (the “Warrant Shares”), from ALTERIX, INC., a Delaware corporation (the “Company”), par value $.01 per share of the Company (the “Common Stocks”), as provided below. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(a) below, as adjusted.